IM Cannabis Corp. Files April 2025 6-K Report

Ticker: IMCC · Form: 6-K · Filed: 2025-04-11T00:00:00.000Z

Sentiment: neutral

Topics: reporting, foreign-private-issuer

TL;DR

IM Cannabis Corp. filed their April 6-K, confirming they're a foreign private issuer filing 20-F.

AI Summary

IM Cannabis Corp. filed a Form 6-K on April 11, 2025, reporting for the month of April 2025. The company, incorporated in A1 with its principal executive offices in Vancouver, British Columbia, is a foreign private issuer. This filing indicates they will file annual reports under Form 20-F.

Why It Matters

This filing provides an update on IM Cannabis Corp.'s reporting status as a foreign private issuer, which can affect how investors interpret their financial disclosures.

Risk Assessment

Risk Level: low — This is a routine reporting form for a foreign private issuer and does not contain specific financial or operational news.

Key Players & Entities

FAQ

What is the primary purpose of this Form 6-K filing for IM Cannabis Corp.?

The primary purpose is to report for the month of April 2025 as a foreign private issuer and to indicate that the company files annual reports under Form 20-F.

When was this Form 6-K filed with the SEC?

This Form 6-K was filed on April 11, 2025.

Where are IM Cannabis Corp.'s principal executive offices located?

IM Cannabis Corp.'s principal executive offices are located at 3606 – 833 Seymour Street, Vancouver, British Columbia V6B 0G4.

Does IM Cannabis Corp. file its annual reports as a Form 20-F or Form 40-F?

IM Cannabis Corp. indicates that it files annual reports under cover of Form 20-F.

What is the Commission File Number for IM Cannabis Corp.?

The Commission File Number for IM Cannabis Corp. is 001-40065.

From the Filing

0001178913-25-001280.txt : 20250411 0001178913-25-001280.hdr.sgml : 20250411 20250411071514 ACCESSION NUMBER: 0001178913-25-001280 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20250411 FILED AS OF DATE: 20250411 DATE AS OF CHANGE: 20250411 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IM Cannabis Corp. CENTRAL INDEX KEY: 0001792030 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40065 FILM NUMBER: 25829850 BUSINESS ADDRESS: STREET 1: KIBBUTZ GLIL YAM CITY: CENTRAL DISTRICT STATE: L3 ZIP: 4690500 BUSINESS PHONE: 416-256-4202 MAIL ADDRESS: STREET 1: KIBBUTZ GLIL YAM CITY: CENTRAL DISTRICT STATE: L3 ZIP: 4690500 6-K 1 zk2533007.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934   For the month of April 2025   Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) 3606 – 833 Seymour Street, Vancouver, British Columbia V6B 0G4 (Address of principal executive offices)   Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F ☒  Form 40-F ☐   Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____   Note : Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.   Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____   Note : Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant's "home country"), or under the rules of the home country exchange on which the registrant's securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant's security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.   SIGNATURE   Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.       IM CANNABIS CORP.     (Registrant)         Date: April 11, 2025 By: /s/ Oren Shuster     Name: Oren Shuster     Title: Chief Executive Officer and Director   EXHIBIT INDEX   99.1 News Release dated April 11, 2025 - IM Cannabis Provides Corporate Updates EX-99.1 2 exhibit_99-1.htm EXHIBIT 99.1 Exhibit 99.1 IM Cannabis Provides Corporate Updates   TORONTO and GLIL YAM, Israel, April 11, 2025/CNW/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the “ Company ”, “ IM Cannabis ”, or “ IMC ”), a leading medical cannabis company with operations in Israel and Germany, today announced the following corproate updates.   Nasdaq Notification Letter   The Company has received a written notification (the “ Notification Letter ”) from the Nasdaq Stock Market LLC (“ Nasdaq ”) dated April 9, 2025, notifying the Company that it is no longer in compliance with Nasdaq Listing Rule 5550(b)(1).   Nasdaq Listing Rule 5550(b)(1) (the &#

View on Read The Filing